FDA developing "industry rights" document on retaliation, agency tells Sen. Gregg.
This article was originally published in The Tan Sheet
Executive Summary
FDA "INDUSTRY RIGHTS" DOCUMENT ON RETALIATION/DISPUTE RESOLUTION will be developed by the agency's Chief Mediator and Ombudsman Office, FDA Commissioner David Kessler said in a June 29 letter to Sen. Judd Gregg (R-N.H.). "In order to enhance the industry's knowledge and use" of the Ombudsman office, which Kessler described as a "resource" for problem resolution between industry and the agency, the commissioner has directed the office "to prepare a document that will outline industry's rights and describe the agency's processes for both retaliation and dispute resolution."